Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 791-800 of 2932 for cancer

Edit search filters
  1. A Study To Evaluate Pemetrexed And Pembrolizumab To Treat Recurrent And/or Metastatic Salivary Gland Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study Of The Safety, Effectiveness And Maximum Tolerated Dose Of Oral PQR309 For Patients With Advanced Solid Tumors

    Rochester, MN

  3. Sonocloud-9 In Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU Or TMZ) In Recurrent GBM

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Of SC-006 In Subjects With Advanced Cancer

    Rochester, MN

  5. A Study To Assess Adverse Events Of Intravenously (IV) Infused ABBV-383 In Adult Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Study To Evaluate The Safety And Effectiveness Of Pembrolizumab Compared To Placebo In Resected High-risk Stage II Melanoma Patients

    Jacksonville, FL, Rochester, MN

  7. 177Lu-DTPA-Omburtamab Radioimmunotherapy ToTreat Recurrent Or Refractory Medulloblastoma

    Rochester, MN

  8. A Study To Evaluate Gevokizumab With Standard Of Care Anti-cancer Therapies For Metastatic Colorectal, Gastroesophageal, And Renal Cancers

    Scottsdale/Phoenix, AZ

  9. FORTIFI-HN01: A Study Of Ficerafusp Alfa (BCA101) Or Placebo In Combination With Pembrolizumab In First-Line PD-L1-pos, R Or M HNSCC

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Comparing Combinations Of Drugs To Treat Newly Diagnosed Multiple Myeloma (NDMM) When A Stem Cell Transplant Is Not A Medically Suitable Treatment

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer